Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00000331

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependent volunteers.

Detailed description

not available at this time

Conditions

Interventions

TypeNameDescription
DRUGTest Drug
DRUGPlacebo Drug

Timeline

Start date
2002-12-01
Primary completion
2002-12-01
Completion
2002-12-01
First posted
1999-09-21
Last updated
2017-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000331. Inclusion in this directory is not an endorsement.